UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin (IL)-17A and IL-17F inhibitor, with ...

Cantu, who is based full-time in Boston, is a co-founder of the Concussion Legacy Foundation (CLF) as well as Boston University’s CTE Center. Back in 2018, CLF began urging that football under ...

LEO Pharma A/S, a global leader in medical dermatology, has today announced its submission of a New Drug Application (NDA) to ...

1-28 New late-breaking Anzupgo® (delgocitinib) cream data will include the full results of the Phase 3 head-to-head DELTA ...

This year, chikungunya patients in Pune are experiencing a range of atypical symptoms, including mild fevers, persistent joint pain, and chickenpox-like rashes. Medical professionals are observing a ...

Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union ...

AN urgent ‘do not eat’ warning has been issued over chicken nuggets, as undeclared ingredients could put some at risk of dangerous allergic reactions. The Food Standards Agency (FSA) ...

Read full article: Teen and adult dead, 5 others hospitalized after home collapses on family in Brazoria County Read full ...

Seasonal allergies can cause more than just a stuffy nose. In some people, the condition can exacerbate mood disorders or related symptoms. Multiple studies have suggested an overlap between ...

GSK plc (LSE/NYSE: GSK) today announced positive topline data from the phase 3 trial in adults 50 years and older evaluating the immunogenicity, reactogenicity and safety of AREXVY (Respiratory ...